Diagnosis of the disease requires a comprehensive assessment of clinical performance, imaging, laboratory testing, and pathology. The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnoses and treatment regimens. Treatment for the management of the disease involves the development of individualized treatments, typically drug therapy, rehabilitation interventions, regular follow-up, and more.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of type I thyroiditis.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.